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The area of Infectious Diseases and Vaccines has been the target for
several publications in previous volumes in this scientific series. Over the
last decade, HIV has been extensively studied, and a variety of vaccine
constructs and strategies have been explored. Lack of adequate CD4+ T cell
help in HIV-1 infected individuals may be one of the main determinants of
the functional impairment of CTL and the eventual failure of immune control
of viremia and clinical disease progression. In a very didactic article, N.L.
LETVIN et al. discuss current understanding of the roles of cellular and
humoral immunity in the containment of HIV-1 replication and describe
nonhuman primate models used for assessing HIV-1 vaccine strategies.
Although rarely pathogenic, mildly virulent mycobacteria, including BCG
and most environmental mycobacteria (EM), may cause a variety of clinical
diseases. M. tuberculosis, M. leprae, and M. ulcerans are more virulent,
causing tuberculosis, leprosy, and Buruli ulcer, respectively. Exposure to
most mycobacteria probably results only rarely in infection. It is clear that
only a minority of the individuals infected go on to develop clinical disease.
Thus, vulnerability to mycobacteria is the exception rather than the rule in
humans, and rare patients with Mendelian disorders have been found to be
vulnerable to BCG, a few EM, and M. tuberculosis. In an excellent chapter,
J. L. CASANOVA & L. ABEL review current genetic knowledge concerning
the inheritance of predisposition to mycobacterial diseases in humans during
natural conditions of infection.
Five chapters are dedicated to Lymphocyte and NK Receptors. There is
growing evidence that T cells that can respond to self-antigens are present in
the peripheral immune repertoire of all humans and some experimental
animals. T cells reactive with myelin antigens and other self-antigens can
readily be expanded and cloned from the peripheral blood of healthy
individuals. Animals immunized with myelin develop an autoimmune
demyelinating disease of CNS called experimental autoimmune
encephalomyelitis (EAE) that serves as a model of the human multiple sclerosis
(MS). V.K. KUCHROO et al. propose a model of EAE and discuss how thymic
expression of tissue myelin antigens, and how reactivity with self-and-cross-
reactive antigens in the peripheral immune compartment might shape, tune,
and regulate the autoreactive T cell repertoire. Natural killer (NK) cells
participate in early, innate defense mechanisms through cytotoxic activity
against pathogen-infected cells and secretion of cytokines and chemokines
that modulate subsequent steps in the adaptative immune response. NK cells
can be activated by dangerous cells in several ways, but many mechanisms
remain poorly understood. Best identified of the events that activate NK cells
is reduced cell-surface expression of MHC class I molecules. NK cells detect
down regulation of MHC class I molecules by means of specific membrane
receptors, which under most circumstances prevent NK cells from responding
to healthy cells expressing the normal complement of autologous MHC class
I molecules. One main category of these inhibitory receptors - the killer-cell-
immunoglobulin-like receptor (KIR) family - has been defined in humans. C.
VILCHES and P. PARHAM discuss how KIR genes have evolved in primates
to generate a diverse family of receptor with unique structures that enable
them to recognize MHC-class I molecules with locus and allele-specificity,
and to modulate innate and adaptative immune responses to specific challenges.
K. NATARAJAN et al. summarize, in a very didactic way, the structures of
the murine and human NK cell receptors that have recently been determined,
with emphasis on how they bind different region of their MHC-I ligands, and
how this allows the discrimination of tumor or virus-infected cells from normal
cells of the host. Immune cells are activated as a result of productive interactions
between ligands and various receptors known as immunoreceptors. Signal
transduction refers to the process by which extracellular events are transmitted
via a receptor or multiple receptors to the interior of the cell. The change in
the receptor induced by binding results in kinase activation, phosphorilation
of proteins, and cellular activation. Critical kinase substrates include effector
enzymes and adapter or linker molecules, which are proteins lacking enzymatic
activity. L.E. SAMELSON reviews certain issues common to various signaling
systems, and focuses on the role of adapters in TCR-mediated activation. A.
VEILLETTE et al. summarize the signaling machinery involved in
immunoreceptor-mediated cell activation, and cover the current knowledge
regarding the negative regulation of immune cell activation.
The field of Lymphocyte Surface Antigens and Activation
Mechanisms is examined in two chapters. T cell activation is dependent
upon signals delivered through the antigen-specific T cell receptor and
accessory receptors on the T cell. The CD28/CTLA-4/ B7-1/B7-2 family
provides a paradigm to define new related immune pathways. B.M.
CARRENO & M. COLLINS review new pathways for costimulation and
inhibition of the B7 family of ligands and its receptors, and discuss how
integration of signals through this family of costimulatory and inhibitory
receptors and their ligands may be critical for activation of immune responses
and tolerance. N. ISAKOV & A. ALTMAN discuss the selective expression
of the novel protein Kinase C (PKC) isoform, PKC-θ, in T cells, as well as
its essential role in T cell antigen receptor (TCR)-triggered activation of
mature T lymphocytes.
Much information has been obtained on the area of Lymphocyte
Development and Differentiation. As pointed out by T. HONJO et al., one
of the most striking facts of the complete human genome sequencing is that
the human genome may contain as few as 30,000 genes, only twofold more
than those in the fruit fly or worm genomes. One strategy to overcome such
a small number of genes is somatic alteration of genetic information after
birth. The authors first compare recent advances in molecular mechanisms
of class switch recombination and somatic hypermutation. Next, a unified
model of regulation of these two different types of genetic alteration
mechanisms by activation-induced cytidine deaminase (AID), a putative RNA
editing enzyme, is discussed. B-1a (CD5+) cells can be distinguished from
all other B cells by surface phenotype and have a number of characteristic
properties. In vitro, they are long lived, refractory to activation through B
cell receptor (BCR) ligation, and, in contrast to B-2 cells, proliferate by
treatment with phorbol esters. In a very interesting review, R. BERLAND
and H.H. WORTIS focus on origins and role of B-1 cells in the production
of natural serum IgM, in the production of IgA in the mucosal immune
system, and autoimmunity. The function of CD5+ molecule as a negative
regulator of BCR signaling that may help prevent inappropriate activation
of autoreactive B-1a cells is also discussed. Self-renewing, hematopoietic
stem cells (HSC) are multipotent, capable of generating erythroid, myeloid,
dendritic, and lymphoid cell lineages. B and T lymphocytes arise from HSCs
through the coordinated action of a class of transcription factors known as
the helix-loop-helix proteins (HLH). M.W. QUONG et al. summarize recent
data and examine the various functions of class I HLH proteins, also known
as E proteins, and their antagonists throughout lymphoid maturation. Finally,
the role of one of the E proteins (E47) as a tumor supressor is also discussed.
The cell´s DNA must be packaged and organized in a manner compatible
with a number of nuclear events, including differential gene transcription,
DNA replication, gene recombination, and cell division. In a given cell type,
decondensed chromatin is primarily associated with genes that must be
accessible to the machinery involved in transcription and recombination.
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The transitions between condensed and decondensed chromatin are thought
to be critical for regulating these processes. By other hand, the acquisition
of a more condensed chromatin structure is often associated with gene
silencing. S.T. SMALE AND A.G. FISHER review recent progress toward
understanding the role of chromatin structure and gene regulation in the
immune system. In typical primary immune responses, the elimination of
effector T cells at the end of the response is incomplete and a small proportion
of T cells survive to become long-lived memory cells. In a didactic and up-
to-date chapter, J. SPRENT & C.D. SURH first consider some of the relevant
features of naïve T cells in unstimulated animals. After that, the authors
review the origin and differentiation of memory T cells and the factors
controlling the long-term survival of these cells.
The area of Regulation of Immune Response is reviewed in three
chapters. The immune system has for many years been known to be
influenced by glucocorticoids. This physiological regulation of the immune
system by glucocorticoids is only one part of reciprocal regulation between
the CNS and immune system through which the CNS signals the immune
system via hormonal and neuronal pathways and the immune system signals
the CNS through cytokines. J.I. WEBSTER et al. review the regulation of
the immune response via the neuroendocrine system, focusing on the effects
of interruptions of this regulatory loop at multiple levels in predisposition
and expression of immune diseases and on mechanisms of glucocorticoid
effects on immune cells and molecules. Innate immune cells such as dendritic
cells (DC) must be activated in order to trigger the generation of optimal
adaptative immune responses. These cells display a set of pattern recognition
receptors (PPRs), which have a general ability to detect certain molecular
structures present in pathogens but not in vertebrate genomic DNAs.
Manipulation of PPR-activated pathways may be useful both for the purposes
of activating therapeutic responses in cancer or some infectious diseases
and also for preventing undesirable immune activation in other human
diseases. In a very up-to-date chapter, A.M. KRIEG discusses a recently
described PPR ligand - the unmethylated CpG dinucleotides - that are
prevalent in pathogens but are suppressed and methylated in vertebrate
genomic DNAs. The author also reviews the immune recognition of CpG
motifs as a defense mechanism, types of CpGDNA, cellular immunology
of CpG and induction of Th1-type immune responses, mechanisms of action,
therapeutic applications of CpGDNA in treatment of cancer, allergic diseases,
and adverse effects of CpGDNA. Innate immunity is an evolutionarily ancient
part of the host defense mechanisms. It covers many areas of host defense
against pathogenic microbes, including the recognition of pathogen-
associated molecular patterns (PAMPs). Whereas the mechanism of
generating receptors in the adaptative immune system involves great
variability and rearrangement of receptor gene segments, the innate immune
recognition relies on a limited number of germline-encoded receptors. In
an excellent chapter, C.A.A JANEWAY & R.M. MEDZHITOV review the
mechanisms of recognition that are truly innate, such that the genes encoded
in the germline DNA and do not require the gene rearrangement essential to
adaptative immune recognition.
In the field of MHC, P. GUERMONPREZ et al. summarize recent
advances in the cell biology of antigen uptake and presentation and focus on
the extraordinary efficiency of dendritic cells for T cell stimulation, initiation
of immune response and induction of tolerance. Finally, the use of dendritic
cells for active immunotherapy is discussed. Heat shock proteins (HSPs) are
abundant soluble intracellular proteins, present in all cells, that appeared at
very dawn of life. Members of the HSP family appear to play a key role in
fundamental immunological phenomena such as activation of antigen
presenting cells, indirect presentation, and chaperoning of peptides during
antigen presentation. In an attractive review, P. SRIVASTAVA first focuses on
differences and similarities between HSPs and the MHC proteins. Next, the
author reviews the primordial functions of the HSPs in innate immunity. At
the end, the many paths where the functions of the MHC proteins and the
HSPs converge are discussed in a very didactic way. Gene-chips contain
thousands of nucleotide sequences that allow simultaneous analyses of the
complex mixture of RNAs transcribed in cells. Analogous to gene-chips, the
peptides displayed by MHC molecules represent the entire ensemble of
polypeptides expressed within a cell. The MHC molecules and the sets of
peptides they display can therefore be considered nature gene-chips that are
probed by the CD8+T cell repertoire. The pathway that generates the peptide-
receptive MHC I involves several steps and key components. In a interesting
issue, N. SHASTRI et al. focus on the less well understood aspects of the
pathway that generates antigenic peptides and suggest a general model for
the peptide/MHC I antigen processing pathway.
The study of animal models of mucosal inflammation as a means to probe
the pathogenesis of inflammatory bowel disease (IBD) extends back a half
century. These historically important models revealed the critical role of
mucosal microflora in the pathogenesis of mucosal inflammation and the
related role of barrier function as a bulwark against extensive stimulation of
the mucosal immune system by the microflora. In a very interesting chapter,
W. STROBER et al. discuss newer models of mucosal inflammation that reflect
a wide variety of causes. Nevertheless, as emphasized by the authors, the
resulting inflammation that develops is almost always channeled into a final
common pathway of inflammation, mediated by either an excessive Th1
response associated with excessive IL-12/IFN-γ/TNF-α secretion or an
excessive Th2 response associated with increased IL-4/IL-5 secretion.
Two chapters are dedicated to Cytokines. Several cell types involved
in immune responses interact with and cross-regulate each other, and the
target cells respond using signal transduction pathways to mediate gene
expression and immune function. MAP kinases are among the most ancient
and evolutionarily conserved signal transduction pathways, and are widely
used throughout evolution in many physiological processes. C. DONG et
al. focus on recent progress on the function and regulation of MAP kinases
in different components or phases of immune responses, with particular
focus on the studies achieved through mouse genetic approaches. The TNF-
family RNAK-L (RANK-L, TRANCE, ODF) and its receptor RANK are
key regulators of bone remodeling, and they are essential for the development
and activation of osteoclasts. These recently described molecules have also
critical functions in immunity and couple lymphoid cells with other organ
systems such as bone morphogenesis and mammary gland formation in
pregnancy. L.E. THEILL et al. review the biological functions of RANK-L,
its receptor RANK, and the decay receptor OPG. Interventions involving
these proteins for development of new therapies for osteoporosis, tooth loss,
arthritis, or bone metastases in cancer are also discussed.
The two dominant mechanisms of contact-dependent lymphocyte-
mediated cytotoxicity are the granule exocytosis and the Fas pathways. The
biological significance of these pathways in various in vivo settings, the
molecular components of these pathways, and the possible therapeutic
interventions to control autoimmune diseases and graft vs. host disease through
these two cytotoxic systems are focused by J.H. RUSSELL & T.J. LEY in a
very interesting chapter. Phagocyte-microbe contact is accompanied by
intracellular signals that trigger cellular processes as cytoskeletal
rearrangement, alterations in membrane trafficking, activation of microbial
killing mechanisms, production of pro-and anti-inflammatory cytokines and
chemokines, activation of apoptosis, and production of molecules required
for efficient antigen presentation to the adaptative immune system. In an
excellent review, D.M. UNDERHILL & A. OZINSKY examine this complexity
focusing their discussion specifically on phagocytosis of microbes.
Finally, the excellent prefatory chapter written by Charles A. JANEWAY,
Jr “A trip through my life with an immunological theme” is obligatory to all
readers. This volume 20 of the Annual Review of Immunology offers a
broad of recent information on selected topics in Basic Immunology, and is
mostly targeted to posgraduates and researchers in various fields of
Immunology.
Myrthes Toledo BARROS, PhD, M.D.
Disciplina de Imunologia Clínica e Alergia
Hospital das Clínicas da Faculdade de
Medicina da Universidade de São Paulo
ANNUAL REVIEWS INC.
4139 El Camino Way, P.O. Box 10139
PALO ALTO, CALIFORNIA 94303-0139 – U.S.A.
